Moreover, other expression analyses revealed decreases in the abundance of SLC35F4 in various tumor types [44], suggesting that its loss may disrupt cofactor homeostasis or Golgi-associated signaling, thereby influencing metabolic reprogramming or antioxidant responses in cancer cells. The gene discussed is SLC35F4; the disease is cancer.